Form 8-K · Current report
Realty Income 8-K, filed Aug 12, 2026
- Filed
- CIK
- 0000726728
- Accession no.
- 0001104659-26-094314
Summary
Realty Income priced an upsized $875.0 million offering of 3.750% convertible senior notes due 2031 in a private placement to qualified institutional buyers, up from a previously announced $750.0 million, with settlement scheduled for August 14, 2026. The company plans to use roughly $188.7 million of net proceeds to repurchase about 3.0 million common shares and $29.1 million to fund capped call transactions.
Key points
- The notes carry a 3.750% annual rate paid semi-annually beginning February 15, 2027, and mature August 15, 2031.
- The initial conversion price is about $72.72 per share, a 17.5% premium to the $61.89 closing price on August 11, 2026.
- Realty Income granted the initial purchasers an option for up to an additional $125.0 million principal amount of notes.
- Estimated net proceeds are about $859.0 million, or about $981.9 million if the purchase option is fully exercised.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01. Other Events. On August 11, 2026, Realty Income Corporation (the “Company”) issued a press release announcing the pricing of the previously announced offering of the Company’s 3.750% Convertible Senior Notes due 2031 (the “Notes”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.